CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		3 Months Ended				9 Months Ended		12 Months Ended
		Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Operating activities
Net increase (decrease) in net assets resulting from operations attributable to participating securities		$ 30,548		$ 15,000		$ 89,680	$ 37,108
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Payment-in-kind interest income						(14,440)	(2,043)
Net accretion of discount on investments						(18,687)	(1,351)
Amortization of deferred financing costs		357		254		897	851
Amortization of discount on unsecured notes						260	0
Sales and repayments of investments						532,515	71,019
Purchases of investments						(785,784)	(46,408)
Net realized (gain) loss from investments						21,134	341
Net change in unrealized (appreciation) depreciation on investments						30,338	1,796
(Increase) decrease in operating assets:
Interest and dividend receivable						(4,994)	(2,856)
Receivable for unsettled trades						(6,686)	(9,807)
Prepaid expenses and other assets						3,431	(1,270)
Due from broker						647	(8,336)
Cash received in the Mergers						58,478	0
(Increase) decrease in operating liabilities:
Management fees payable						10,884	72
Incentive fee on income payable						6,099	0
Accounts payable and accrued expenses						(4,345)	3,097
Interest and debt fees payable						18,245	4,869
Directors' fees payable						(397)	158
Other liabilities						550	(196)
Net cash provided by (used in) operating activities						(62,175)	47,044
Financing activities
Repayments on secured borrowings						(2,586)	33,344
Proceeds from issuance of shares of common stock						900	9,922
Proceeds from issuance of shares of preferred stock						0	41,353
Repurchase of common stock						(43,017)	0
Proceeds from debt						801,724	32,000
Payments on debt						(508,974)	(70,400)
Proceeds from short-term borrowings						0	68,583
Repayments on short-term borrowings						0	(89,375)
Payments of financing costs						(4,424)	0
Common stockholder distributions						(77,434)	(23,268)
Preferred stockholder distributions						(5,570)	(5,417)
Net cash provided by (used in) financing activities						160,619	(3,258)
Net increase (decrease) in cash, cash equivalents and restricted cash						98,444	43,786
Cash, cash equivalents and restricted cash, beginning of period			$ 55,222		$ 26,239	55,222	26,239	$ 26,239
Cash, cash equivalents and restricted cash, end of period		153,666		70,025		153,666	70,025	55,222
Supplemental information:
Interest and non-usage fees paid during the period						63,742	17,306
Taxes, including excise tax, paid during the period						4,327	325
Distributions reinvested during the period		9,803	$ 3,342	3,141	$ 2,994	23,078	9,210	12,439
Issuance of shares in connection with merger	[1]					1,594,261	0
Cash and cash equivalents		135,387		70,025		135,387	70,025	48,541
Restricted cash		18,279		0		18,279	0	6,681
Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows		$ 153,666		$ 70,025		$ 153,666	$ 70,025	$ 55,222

[1] On January 24, 2024, in connection with the Mergers (as defined in Note 1 – Organization), the Company acquired net assets of $1,594.3 million for the total stock consideration of $1,598.9 million, inclusive of $4.6 million of transaction costs. For further details, refer to Note 17 – Merger with FBLC.